A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)

  • Tran, Huyen (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date20/01/23 → 19/01/25

Keywords

  • Clinical trial
  • Haematological malignancy
  • VTE